A Safety and Immune Response Study of 2 Experimental HIV Vaccines

NCT02404311 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

252

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

BIOLOGICAL: ALVAC-HIV
BIOLOGICAL: Bivalent Subtype C gp120/MF59®
BIOLOGICAL: ALVAC-HIV (vCP2438) Placebo
BIOLOGICAL: Bivalent gp120/MF59® Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]